Global & Public Health (all articles)
Long Covid: Comprehensive health assessment three months after recovery from acute COVID-19 revealed problems in several health domains in a substantial number of patients
27 Nov, 2020 | 08:33h | UTC
Covid-19: 15% of people responsible for 80% of secondary infections
27 Nov, 2020 | 08:27h | UTCTransmission heterogeneities, kinetics, and controllability of SARS-CoV-2 – Science
Commentary: What we can learn from contact tracing an entire province – Ars Technica
Commentary on Twitter
Study of 1,178 #COVID19 cases & their 15,648 contacts in Hunan, China. Just 15% of people were responsible for 80% of secondary infections.
Children were less likely to be infected than young to middle-aged adults, but infectiousness didn’t differ by age.https://t.co/PYaj9pbSJo pic.twitter.com/mREh5wWkKd
— Dr Zoë Hyde (@DrZoeHyde) November 26, 2020
Perspective: “With global push for COVID-19 vaccines, China aims to win friends and cut deals”
27 Nov, 2020 | 08:26h | UTCWith global push for COVID-19 vaccines, China aims to win friends and cut deals – Science
CDC may shorten how long you quarantine if you are exposed to Covid-19 coronavirus
26 Nov, 2020 | 09:06h | UTCCDC May Shorten How Long You Quarantine If You Are Exposed To Covid-19 Coronavirus – Forbes
India coronavirus: How do you vaccinate a billion people?
27 Nov, 2020 | 08:24h | UTCIndia coronavirus: How do you vaccinate a billion people? – BBC
CDC Study showing decline in SARS-CoV-2 antibodies after infection suggests antibody surveys underestimate infections
26 Nov, 2020 | 09:08h | UTCCommentary: COVID-19 antibody surveys underestimate infections: study – MedicalXpress
Commentary on Twitter (Thread – Click for more)
1/?Precipitous decline in #SARSCoV2 antibodies: study participants who'd been infected and had detectable antibodies were retested 60 days later. 94% showed antibody decline & 28% had no detectable antibodies. They had "seroreverted". How that impacts reinfection risk is unknown pic.twitter.com/QsvQTE9jVH
— Dr. Ali Nouri (@AliNouriPhD) November 25, 2020
Should COVID-19 vaccines be mandatory? Two experts discuss
26 Nov, 2020 | 09:05h | UTCShould COVID-19 vaccines be mandatory? Two experts discuss – The Conversation
Testing sewage can give school districts, campuses and businesses a heads-up on the spread of COVID-19
26 Nov, 2020 | 09:03h | UTC
Opinion: “The AstraZeneca Covid Vaccine Data Isn’t Up to Snuff”
26 Nov, 2020 | 09:02h | UTCThe AstraZeneca Covid Vaccine Data Isn’t Up to Snuff – Wired
Commentaries: A timeline of the oxford-Astrazeneca Covid-19 vaccine trials – by Hilda Bastian AND After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine – The New York Times AND AstraZeneca manufacturing error clouds vaccine study results – Associated Press
Cluster-randomized trial: Postexposure hydroxychloroquine does not prevent Covid-19 in healthy persons exposed to a PCR-positive case patient
25 Nov, 2020 | 09:15h | UTC
Commentary on Twitter
Another RCT in @NEJM of outpatient treatment with Hydroxychloroquine in high risk folks to prevent COVID transmission
No benefit
But about 10X rate of adverse events in HCQ group
Happy to keep studying HCQ
But it really doesn't look like it workshttps://t.co/9nAfir0CMX
— Ashish K. Jha, MD, MPH (@ashishkjha) November 24, 2020
[Preprint] Study shows cloth face coverings help protect both wearers and those nearby. Study design represents conditions closer to real-world use, with the control of laboratory testing
25 Nov, 2020 | 09:11h | UTCStudy shows cloth face coverings help protect both wearers and those nearby – Virginia Tech
Original study: Inward and outward effectiveness of cloth masks, a surgical mask, and a face shield – medRxiv
With more data on its COVID-19 vaccine, Russian institute offers new evidence of success
25 Nov, 2020 | 09:13h | UTCWith more data on its COVID-19 vaccine, Russian institute offers new evidence of success – Science
Commentaries: Expert reaction to press release reporting the second interim analysis of the efficacy of the Sputnik V vaccine – Science Media Centre AND Russia says Sputnik V virus vaccine 95% effective – MedicalXpress
Opinion: “Children may transmit coronavirus at the same rate as adults: what we now know about schools and COVID-19”
25 Nov, 2020 | 09:09h | UTC
Commentary from the author on Twitter
I've written a new article describing what we know about children, schools, & #COVID19.
➡️ Children & adults are equally susceptible, & likely transmit the virus at the same rate.
➡️ Schools are a driver of the second wave in Europe, Canada, & elsewhere.https://t.co/25T9HwHBlt
— Dr Zoë Hyde (@DrZoeHyde) November 24, 2020
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
25 Nov, 2020 | 09:10h | UTCLatest COVID-19 guidelines come out against bamlanivimab, remdesivir – ACP Internist
Systematic review: Financial payments from the pharmaceutical industry is associated with more physician prescribing of the drug made by the company that they got the payments from
25 Nov, 2020 | 09:07h | UTCAre Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Financial payments from drug industry associated with physician prescribing – American College of Physicians
Commentary from the author on Twitter (thread – click for more)
"Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?"
Our latest on physician-industry COI is out today in @AnnalsofIM!Not to bury the lede, the answer is "yes."
Thread to follow.https://t.co/2lfAjWSQuq
1/— Aaron Mitchell (@TheWonkologist) November 24, 2020
Randomized trial: Colorectal cancer screening with repeated fecal immunochemical tests detects more colorectal cancer and advanced adenomas compared to screening sigmoidoscopy
25 Nov, 2020 | 09:05h | UTCColorectal cancer screening with repeated fecal immunochemical test versus sigmoidoscopy: baseline results from a randomized trial – Gastroenterology (link to abstract – $ for full-text)
USPSTF Statement recommends regular behavioral counseling on healthy diet and physical activity to prevent cardiovascular disease
25 Nov, 2020 | 08:59h | UTCAuthor interview: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors
JAMA Patient Page: Counseling on Healthy Diet and Physical Activity to Prevent Cardiovascular Disease
Kids’ COVID cases on the rise, but most are mild, new studies show
24 Nov, 2020 | 09:35h | UTCKids’ COVID cases on the rise, but most are mild, new data show – CIDRAP
Why does the AstraZeneca-Oxford COVID-19 vaccine’s efficacy vary so much? Here’s what we know
24 Nov, 2020 | 09:30h | UTCWhy Does the AstraZeneca COVID-19 Vaccine’s Efficacy Vary So Much? Here’s What We Know – TIME
Related: Why Oxford’s positive COVID vaccine results are puzzling scientists – Nature
Why the AstraZeneca-Oxford Covid-19 vaccine is different. It does not require extremely cold temperatures for storage, and the price will be “a fraction” of the expense of the other vaccine candidates
24 Nov, 2020 | 09:32h | UTCWhy the AstraZeneca-Oxford Covid-19 vaccine is different – Vox
Four reasons why we need multiple vaccines for Covid-19
24 Nov, 2020 | 09:27h | UTCFour reasons why we need multiple vaccines for Covid-19 – Wellcome Trust
Emergency COVID-vaccine approvals pose a dilemma for scientists. It could complicate efforts to study long-term outcomes, such as safety, how long protection lasts and whether the jab prevents infection or just the disease
24 Nov, 2020 | 09:28h | UTCWhy emergency COVID-vaccine approvals pose a dilemma for scientists – Nature
Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains
24 Nov, 2020 | 09:25h | UTC
Covid-19: Oxford University vaccine shows 70% protection
23 Nov, 2020 | 09:54h | UTCCovid-19: Oxford University vaccine shows 70% protection – BBC
News release: Oxford University breakthrough on global COVID-19 vaccine
Commentary on Twitter
Today marks an important milestone in the fight against #COVID19. Interim data show the #OxfordVaccine is 70.4% effective, & tests on two dose regimens show that it could be 90%, moving us one step closer to supplying it at low cost around the world>> https://t.co/fnHnKSqftT pic.twitter.com/2KYXPxFNz1
— University of Oxford (@UniofOxford) November 23, 2020
Meta-analysis: SARSCoV2 most contagious within the first 5 days of symptom onset
23 Nov, 2020 | 09:53h | UTCCommentaries: COVID-19 most contagious in first 5 days of illness, study finds – CIDRAP AND Infectiousness peaks early in COVID-19 patients, emphasising the need to rapidly isolate cases – The Lancet AND Covid-19 carriers ‘most infectious earlier on’ – BBC
Commentary on Twitter (thread – click for more)
Our systematic review and meta-analysis on #SARSCoV2, #SARSCoV & #MERSCoV viral load dynamics, duration of viral shedding & infectiousness out now in @LancetMicrobe ?@mugecevik @silverfoxdoc @CVRinfo @UofGlasgow @Infection_StAnd https://t.co/Tac3A2RR3E
— Antonia Ho (@DrToniHo) November 20, 2020